Estados financieros detallados de Shuttle Pharmaceuticals Holdings, Inc. (SHPH): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $3.13, SHPH presenta beneficios negativos (P/E no significativo) y un ROE del -408.33%. La capitalización bursátil es de $2M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $18739 | $18000 | $54951 | $60834 | $5972 | 0 | 0 | 0 |
| Beneficio Bruto | -$18739 | -$18000 | -$54951 | -$60834 | -$5972 | 0 | 0 | 0 |
| I+D | -$836 | $55572 | $161772 | $1.0M | $1.0M | $3.5M | $3.6M | $4.1M |
| Generales y Administrativos | $185987 | $513059 | $347750 | $721184 | $1.3M | $2.4M | $4.1M | $7.9M |
| Gastos Operativos | $185151 | $568632 | $454571 | $1.7M | $2.3M | $5.9M | $7.7M | $11.9M |
| Beneficio Operativo | -$203890 | -$586630 | -$509522 | -$1.7M | -$2.3M | -$5.9M | -$7.7M | -$11.9M |
| EBITDA | -$183971 | -$577223 | -$711151 | -$1.0M | -$4.3M | -$4.0M | -$7.8M | -$11.4M |
| Gastos por Intereses | $10881 | $30916 | $39630 | $50788 | $670610 | $2.6M | $1.4M | $70828 |
| Beneficio Antes de Impuestos | -$213594 | -$626139 | -$805732 | -$1.2M | -$5.0M | -$6.6M | -$9.1M | -$11.7M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$213594 | -$626139 | -$805732 | -$1.2M | -$5.0M | -$6.6M | -$9.1M | -$11.7M |
| BPA | $-0.16 | $-0.46 | $-0.68 | $-0.95 | $-3.00 | $-4.10 | $-8857.30 | $-71.60 |
| BPA Diluido | $-0.16 | $-0.46 | $-0.68 | $-0.95 | $-3.00 | $-4.10 | $-8857.30 | $-71.60 |
| Acciones en Circulación (Diluidas) | $1.4M | $1.4M | $1.4M | $1.4M | $1.0M | $1.6M | $1.0M | $163792 |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$289070 | -$633340 |
| Beneficio Operativo | -$3.9M | -$2.3M | -$2.8M | -$2.2M |
| EBITDA | -$3.7M | -$2.3M | -$2.3M | -$1.5M |
| Beneficio Neto | -$3.7M | -$2.3M | -$2.6M | -$2.2M |
| BPA | $-32.90 | $-10.50 | $-12.90 | $-4.30 |
| BPA Diluido | $-32.90 | $-10.50 | $-12.90 | $-4.30 |
Balance (10 años)
| Año | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $50709 | $352390 | $117153 | $504749 | $8.4M | $2.6M | $1.9M | $334005 |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $2.9M | 0 | 0 |
| Cuentas por Cobrar | $49210 | $3825 | $211455 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $102460 | $613957 | $341187 | $509615 | $8.6M | $5.6M | $2.2M | $502911 |
| Inmovilizado Material | $18838 | $838 | $196380 | $135546 | $68714 | $358731 | $295373 | $119702 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $9.8M |
| Activos Totales | $121298 | $621275 | $544047 | $651641 | $8.7M | $6.0M | $2.5M | $10.5M |
| Cuentas por Pagar | $79104 | $30731 | $516966 | $828313 | $129245 | $283306 | $596600 | $1.5M |
| Deuda a Corto | $314377 | $400000 | $686441 | $849501 | $685473 | $595999 | $874475 | 0 |
| Pasivos Corrientes | $405646 | $593819 | $2.1M | $2.2M | $975676 | $1.0M | $1.5M | $8.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $135089 | 0 | 0 |
| Pasivos Totales | $405646 | $593819 | $2.2M | $2.3M | $975676 | $1.9M | $1.8M | $8.2M |
| Reservas | -$1.3M | -$1.9M | -$4.5M | -$5.8M | -$8.9M | -$25.4M | -$34.6M | -$46.3M |
| Patrimonio Neto | -$284348 | $27456 | -$1.7M | -$1.6M | $7.7M | $4.1M | $709152 | $2.3M |
| Deuda Total | $314377 | $400000 | $874285 | $978877 | $748296 | $1.1M | $1.2M | $232147 |
| Deuda Neta | $263668 | $47610 | $757132 | $474128 | -$7.7M | -$4.4M | -$746672 | -$101858 |
| Capital Circulante | -$303186 | $20138 | -$1.8M | -$1.7M | $7.6M | $4.6M | $677148 | -$7.5M |
Balance (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Caja y Equivalentes | $4.8M | $2.1M | $334005 | $1.1M |
| Activos Totales | $5.5M | $3.5M | $10.5M | $11.8M |
| Pasivos Totales | $1.9M | $2.1M | $8.2M | $8.5M |
| Patrimonio Neto | $3.6M | $1.4M | $2.3M | $3.3M |
| Deuda Total | $712981 | $667331 | $232147 | $214013 |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$213594 | -$626139 | -$805732 | -$1.2M | -$5.0M | -$6.6M | -$9.1M | -$11.7M |
| Amortizaciones | $18739 | $18000 | $54951 | $60834 | $5972 | $6811 | $5463 | $290107 |
| Compensación en Acciones | 0 | 0 | $459589 | $910067 | $237547 | $181960 | $259744 | $932967 |
| Cambio en Capital Circulante | -$9027 | $16647 | $7781 | $519154 | -$462790 | $220634 | $138911 | $540617 |
| Flujo de Caja Operativo | -$202705 | -$566692 | -$26831 | -$300336 | -$2.7M | -$5.6M | -$7.3M | -$9.5M |
| Inversiones (CapEx) | 0 | 0 | -$10818 | 0 | 0 | -$19046 | 0 | $5 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$202705 | -$566692 | -$37649 | -$300336 | -$2.7M | -$5.6M | -$7.3M | -$9.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Flujo de Caja Operativo | -$3.4M | -$2.6M | -$973012 | -$2.4M |
| Inversiones (CapEx) | 0 | $4 | 0 | 0 |
| Flujo de Caja Libre | -$3.4M | -$2.6M | -$973012 | -$2.4M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $46853 | $134318 | $214750 | $35018 |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -193.1% | -28.7% | -43.0% | -333.6% | -32.0% | -38.7% | -28.2% |
| Crecimiento BPA (anual) | | -193.6% | -48.4% | -38.2% | -217.5% | -36.7% | -215931.7% | +99.2% |
| Cambio en Acciones (anual) | | +0.0% | +0.0% | +0.0% | -23.8% | +53.7% | -35.1% | -84.1% |
| Crecimiento FCF (anual) | | -179.6% | +93.4% | -697.7% | -787.8% | -110.0% | -30.8% | -29.4% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.15 | $-0.42 | $-0.03 | $-0.22 | $-2.58 | $-3.52 | $-7.10 | $-57.89 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.4M | $1.4M | $1.4M | $1.4M | $1.0M | $1.6M | $1.0M | $163792 |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -408.33% |
| Rentabilidad sobre capital invertido | -312.04% |
| Rentabilidad sobre activos | -91.63% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.06 |
| Ratio corriente | 0.30 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -10.78 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -490191.08 | -166941.43 | -112514.62 | -81439.15 | -1306.67 | -221.95 | -0.02 | -0.25 |
| P/VC | -367721.53 | 3808307.13 | -61859.51 | -64221.38 | 528.48 | 356.90 | 312.65 | 1.31 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |